Opportunistic Infections Citation List: August 2 - August 15, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Kannurin, a Novel Lipopeptide from Bacillus cereus Strain AK1: Isolation, Structural Evaluation and Antifungal Activities. Ajesh, K., S. Sudarslal, C. Arunan, and K. Sreejith. Journal of Applied Microbiology, 2013. [Epub ahead of print]. PMID[23937170].

[PubMed]. OI_0802-081513.

2. Evaluation of Anti-bacterial and Anti-oxidant Potential of Andrographolide and Echiodinin Isolated from Callus Culture of Andrographis paniculata Nees. Arifullah, M., N.D. Namsa, M. Mandal, K.K. Chiruvella, P. Vikrama, G.R. Gopal, and Z. Khanam. Asian Pacific Journal of Tropical Biomedicine, 2013. 3(8): p. 604-610. PMID[23905016].

[PubMed]. OI_0802-081513.

3. Antimicrobial and Antiurease Activities of Newly Synthesized Morpholine Derivatives Containing an Azole Nucleus. Bektas, H., S. Ceylan, N. Demirbas, S. Alpay-Karaoglu, and B.B. Sokmen. Medicinal Chemistry Research, 2013. 22(8): p. 3629-3639. PMID[23807823].

[PubMed]. OI_0802-081513.

4. New Compounds, Chemical Composition, Antifungal Activity and Cytotoxicity of the Essential Oil from Myrtus nivellei Batt. & Trab., an Endemic Species of Central Sahara. Bouzabata, A., O. Bazzali, C. Cabral, M.J. Goncalves, M. Teresa Cruz, A. Bighelli, C. Cavaleiro, J. Casanova, L. Salgueiro, and F. Tomi. Journal of Ethnopharmacology, 2013. [Epub ahead of print]. PMID[23911425].

[PubMed]. OI_0802-081513.

5. Isolation of (-)-Olivil-9'-o-beta-D-glucopyranoside from Sambucus williamsii and Its Antifungal Effects with Membrane-disruptive Action. Choi, H., J. Lee, Y.S. Chang, E.R. Woo, and D.G. Lee. Biochimica et Biophysica Acta, 2013. 1828(8): p. 2002-2006. PMID[23643888].

[PubMed]. OI_0802-081513.

6. Synthesis, in Vitro Antifungal Activity and in Silico Study of 3-(1,2,4-Triazol-1-yl)flavanones. Emami, S., S. Shojapour, M.A. Faramarzi, N. Samadi, and H. Irannejad. European Journal of Medicinal Chemistry, 2013. 66: p. 480-488. PMID[23831810].

[PubMed]. OI_0802-081513.

7. Synthesis, Biological Evaluation and Molecular Docking Studies of Some Pyrimidine Derivatives. Fargualy, A.M., N.S. Habib, K.A. Ismail, A.M. Hassan, and M.T. Sarg. European Journal of Medicinal Chemistry, 2013. 66: p. 276-295. PMID[23811090].

[PubMed]. OI_0802-081513.

8. Chemical Screening Identifies Filastatin, a Small Molecule Inhibitor of Candida albicans Adhesion, Morphogenesis, and Pathogenesis. Fazly, A., C. Jain, A.C. Dehner, L. Issi, E.A. Lilly, A. Ali, H. Cao, P.L. Fidel, Jr., P.R. R, and P.D. Kaufman. Proceedings of the National Academy of Sciences of the United States of America, 2013. 110(33): p. 13594-13599. PMID[23904484].

[PubMed]. OI_0802-081513.

9. Antifungal Effects of Citronella Oil against Aspergillus niger ATCC 16404. Li, W.R., Q.S. Shi, Y.S. Ouyang, Y.B. Chen, and S.S. Duan. Applied Microbiology and Biotechnology, 2013. 97(16): p. 7483-7492. PMID[23081773].

[PubMed]. OI_0802-081513.

10. Synthesis, Self-aggregation and Biological Properties of Alkylphosphocholine and Alkylphosphohomocholine Derivatives of Cetyltrimethylammonium bromide, Cetylpyridinium bromide, Benzalkonium bromide (C16) and Benzethonium chloride. Lukac, M., M. Mrva, M. Garajova, G. Mojzisova, L. Varinska, J. Mojzis, M. Sabol, J. Kubincova, H. Haragova, F. Ondriska, and F. Devinsky. European Journal of Medicinal Chemistry, 2013. 66: p. 46-55. PMID[23792315].

[PubMed]. OI_0802-081513.

11. Hydroxyaldimines as Potent in Vitro Anticryptococcal Agents. Magalhaes, T.F., C.M. da Silva, A. de Fatima, D.L. da Silva, L.V. Modolo, C.V. Martins, R.B. Alves, A.L. Ruiz, G.B. Longato, J.E. de Carvalho, and M.A. de Resende-Stoianoff. Letters in Applied Microbiology, 2013. 57(2): p. 137-143. PMID[23594040].

[PubMed]. OI_0802-081513.

12. In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds. Pfaller, M.A., S.A. Messer, P.R. Rhomberg, R.N. Jones, and M. Castanheira. Journal of Clinical Microbiology, 2013. 51(8): p. 2608-2616. PMID[23740727].

[PubMed]. OI_0802-081513.

13. cgMolluscidin, a Novel Dibasic Residue Repeat Rich Antimicrobial Peptide, Purified from the Gill of the Pacific Oyster, Crassostrea gigas. Seo, J.K., M.J. Lee, B.H. Nam, and N.G. Park. Fish Shellfish Immunology, 2013. 35(2): p. 480-488. PMID[23711469].

[PubMed]. OI_0802-081513.

14. High-throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors. Siles, S.A., A. Srinivasan, C.G. Pierce, J.L. Lopez-Ribot, and A.K. Ramasubramanian. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3681-3687. PMID[23689719].

[PubMed]. OI_0802-081513.

15. Didehydroroflamycoin (DDHR) Pentaene Macrolide Family from Streptomyces durmitorensis MS405 : Production Optimization and Antimicrobial Activity. Stankovic, N., L. Senerovic, Z. Bojic-Trbojevic, I. Vuckovic, L. Vicovac, B. Vasiljevic, and J. Nikodinovic-Runic. Journal of Applied Microbiology, 2013. [Epub ahead of print]. PMID[23941529].

[PubMed]. OI_0802-081513.

16. Evaluation of (4-Aminobutyloxy)quinolines as a Novel Class of Antifungal Agents. Vandekerckhove, S., H.G. Tran, T. Desmet, and M. D'Hooghe. Bioorganic & Medicinal Chemistry Letters, 2013. 23(16): p. 4641-4643. PMID[23838261].

[PubMed]. OI_0802-081513.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

17. Doubly Prenylated Tryptamines: Cytotoxicity, Antimicrobial Activity and Cyclisation to the Marine Natural Product Flustramine A. Adla, S.K., F. Sasse, G. Kelter, H.H. Fiebig, and T. Lindel. Organic & Biomolecular Chemistry, 2013. [Epub ahead of print]. PMID[23925418].

[PubMed]. OI_0802-081513.

18. Mycobacterium tuberculosis Shikimate Kinase Inhibitors: Design and Simulation Studies of the Catalytic Turnover. Blanco, B., V. Prado, E. Lence, J.M. Otero, C. Garcia-Doval, M.J. van Raaij, A.L. Llamas-Saiz, H. Lamb, A.R. Hawkins, and C. Gonzalez-Bello. Journal of the American Chemical Society, 2013. [Epub ahead of print]. PMID[23889343].

[PubMed]. OI_0802-081513.

19. Development of Mycobacterium tuberculosis Whole Cell Screening Hits as Potential Antituberculosis Agents. Cooper, C.B. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23927683].

[PubMed]. OI_0802-081513.

20. Antibacterial and Herbicidal Activity of Ring-substituted 2-Hydroxynaphthalene-1-carboxanilides. Gonec, T., J. Kos, I. Zadrazilova, M. Pesko, R. Govender, S. Keltosova, B. Chambel, D. Pereira, P. Kollar, A. Imramovsky, J. O'Mahony, A. Coffey, A. Cizek, K. Kralova, and J. Jampilek. Molecules, 2013. 18(8): p. 9397-9419. PMID[23924993].

[PubMed]. OI_0802-081513.

21. Identification of Novel Inhibitors of Nonreplicating Mycobacterium tuberculosis Using a Carbon Starvation Model. Grant, S.S., T. Kawate, P.P. Nag, M.R. Silvis, K. Gordon, S.A. Stanley, E. Kazyanskaya, R. Nietupski, A. Golas, M. Fitzgerald, S. Cho, S.G. Franzblau, and D.T. Hung. ACS Chemical Biology, 2013. [Epub ahead of print]. PMID[23898841].

[PubMed]. OI_0802-081513.

22. Synthesis and Biological Evaluation of 3-(4-Chlorophenyl)-4-Substituted Pyrazole Derivatives. Horrocks, P., M.R. Pickard, H.H. Parekh, S.P. Patel, and R.B. Pathak. Organic & Biomolecular Chemistry, 2013. 11(29): p. 4891-4898. PMID[23779132].

[PubMed]. OI_0802-081513.

23. Discovery of Q203, a Potent Clinical Candidate for the Treatment of Tuberculosis. Pethe, K., P. Bifani, J. Jang, S. Kang, S. Park, S. Ahn, J. Jiricek, J. Jung, H.K. Jeon, J. Cechetto, T. Christophe, H. Lee, M. Kempf, M. Jackson, A.J. Lenaerts, H. Pham, V. Jones, M.J. Seo, Y.M. Kim, M. Seo, J.J. Seo, D. Park, Y. Ko, I. Choi, R. Kim, S.Y. Kim, S. Lim, S.A. Yim, J. Nam, H. Kang, H. Kwon, C.T. Oh, Y. Cho, Y. Jang, J. Kim, A. Chua, B.H. Tan, M.B. Nanjundappa, S.P. Rao, W.S. Barnes, R. Wintjens, J.R. Walker, S. Alonso, S. Lee, J. Kim, S. Oh, T. Oh, U. Nehrbass, S.J. Han, Z. No, J. Lee, P. Brodin, S.N. Cho, K. Nam, and J. Kim. Natural Medicine, 2013. [Epub ahead of print]. PMID[23913123].

[PubMed]. OI_0802-081513.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

24. Antimalarial and Cytotoxic Activities of Chiral Triamines. Dellai, A., J. Appel, A. Bouraoui, S. Croft, and A. Nefzi. Bioorganic & Medicinal Chemistry Letters, 2013. 23(16): p. 4579-4582. PMID[23835293].

[PubMed]. OI_0802-081513.

25. In Vivo Antimalarial Activity of Trichilia megalantha Harms Extracts and Fractions in Animal Models. Fadare, D.A., O.O. Abiodun, and E.O. Ajaiyeoba. Parasitology Research, 2013. 112(8): p. 2991-2995. PMID[23801363].

[PubMed]. OI_0802-081513.

26. Interrogating a Hexokinase-selected Small-molecule Library for Inhibitors of Plasmodium falciparum Hexokinase. Harris, M.T., D.M. Walker, M.E. Drew, W.G. Mitchell, K. Dao, C.E. Schroeder, D.P. Flaherty, W.S. Weiner, J.E. Golden, and J.C. Morris. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3731-3737. PMID[23716053].

[PubMed]. OI_0802-081513.

27. Structure Determination and Total Synthesis of (+)-16-Hydroxy-16,22-dihydroapparicine. Hirose, T., Y. Noguchi, Y. Furuya, A. Ishiyama, M. Iwatsuki, K. Otoguro, S. Omura, and T. Sunazuka. Chemistry, 2013. 19(32): p. 10741-10750. PMID[23788004].

[PubMed]. OI_0802-081513.

28. Structure-activity Relationship Studies of Pyrrolone Antimalarial Agents. Murugesan, D., M. Kaiser, K.L. White, S. Norval, J. Riley, P.G. Wyatt, S.A. Charman, K.D. Read, C. Yeates, and I.H. Gilbert. ChemMedChem, 2013. [Epub ahead of print]. PMID[23918316].

[PubMed]. OI_0802-081513.

29. Synthesis of Carbocyclic Pyrimidine Nucleosides and Their Inhibitory Activities against Plasmodium falciparum Thymidylate Kinase. Noguchi, Y., Y. Yasuda, M. Tashiro, T. Kataoka, Y. Kitamura, M. Kandeel, and Y. Kitade. Parasitology International, 2013. 62(4): p. 368-371. PMID[23583697].

[PubMed]. OI_0802-081513.

30. Synthesis and Bioevaluation of Novel 4-Aminoquinoline-tetrazole Derivatives as Potent Antimalarial Agents. Pandey, S., P. Agarwal, K. Srivastava, S. Rajakumar, S.K. Puri, P. Verma, J.K. Saxena, A. Sharma, J. Lal, and P.M. Chauhan. European Journal of Medicinal Chemistry, 2013. 66: p. 69-81. PMID[23792317].

[PubMed]. OI_0802-081513.

31. In Vivo Antimalarial Activity of Novel 2-Hydroxy-3-anilino-1,4-naphthoquinones Obtained by Epoxide Ring-opening Reaction. Rezende, L.C., F. Fumagalli, M.S. Bortolin, M.G. Oliveira, M.H. Paula, V.F. Andrade-Neto, and S. Emery Fda. Bioorganic & Medicinal Chemistry Letters, 2013. 23(16): p. 4583-4586. PMID[23850202].

[PubMed]. OI_0802-081513.

32. Antiplasmodial Activity of Ethanolic Extracts of Some Selected Medicinal Plants from the Northwest of Iran. Sangian, H., H. Faramarzi, A. Yazdinezhad, S.J. Mousavi, Z. Zamani, M. Noubarani, and A. Ramazani. Parasitology Research, 2013. [Epub ahead of print]

PMID[23922204].

[PubMed]. OI_0802-081513.

33. Synthesis of 4-Aminoquinoline-pyrimidine Hybrids as Potent Antimalarials and Their Mode of Action Studies. Singh, K., H. Kaur, K. Chibale, and J. Balzarini. European Journal of Medicinal Chemistry, 2013. 66: p. 314-323. PMID[23811093].

[PubMed]. OI_0802-081513.

34. Broad-spectrum Antimalarial Activity of Peptido Sulfonyl Fluorides, a New Class of Proteasome Inhibitors. Tschan, S., A.J. Brouwer, P.R. Werkhoven, A.M. Jonker, L. Wagner, S. Knittel, M.N. Aminake, G. Pradel, F. Joanny, R.M. Liskamp, and B. Mordmuller. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3576-3584. PMID[23689711].

[PubMed]. OI_0802-081513.

Citations from the ISI Web of Knowledge Listings for O.I.

35. Synthesis of New Series of 3-Hydroxy/Acetoxy-2-phenyl-4H-chromen-4-ones and Their Biological Importance. Gharpure, M., R. Choudhary, V. Ingle, and H. Juneja. Journal of Chemical Sciences, 2013. 125(3): p. 575-582. ISI[000320684600014].

[WOS]. OI_0802-081513.

36. Identification of Compounds with Potential Antibacterial Activity against Mycobacterium through Structure-based Drug Screening. Kinjo, T., Y. Koseki, M. Kobayashi, A. Yamada, K. Morita, K. Yamaguchi, R. Tsurusawa, G. Gulten, H. Komatsu, H. Sakamoto, J.C. Sacchettini, M. Kitamura, and S. Aoki. Journal of Chemical Information and Modeling, 2013. 53(5): p. 1200-1212. ISI[000319650800017].

[WOS]. OI_0802-081513.

37. Synthesis of New Fluorine Substituted Heterocyclic Nitrogen Systems Derived from P-Aminosalicylic acid as Antimycobacterial Agents. Makki, M., R.M. Abdel-Rahman, H.M. Faidallah, and K.A. Khan. Journal of Chemistry, 2013. ISI[000321360700001].

[WOS]. OI_0802-081513.

38. Antifungal Vanillin-imino-chitosan Biodynameric Films. Marin, L., I. Stoica, M. Mares, V. Dinu, B.C. Simionescu, and M. Barboiu. Journal of Materials Chemistry B, 2013. 1(27): p. 3353-3358. ISI[000320664200003].

[WOS]. OI_0802-081513.

39. Effects of Chitosan on Candida albicans: Conditions for Its Antifungal Activity. Pena, A., N.S. Sanchez, and M. Calahorra. Biomed Research International, 2013. 527549 . ISI[000321384000001].

[WOS]. OI_0802-081513.

40. Modification of Triclosan Scaffold in Search of Improved Inhibitors for Enoyl-Acyl Carrier Protein (ACP) Reductase in Toxoplasma gondii. Stec, J., A. Fomovska, G.A. Afanador, S.P. Muench, Y. Zhou, B.S. Lai, K. El Bissati, M.R. Hickman, P.J. Lee, S.E. Leed, J.M. Auschwitz, C. Sommervile, S. Woods, C.W. Roberts, D. Rice, S.T. Prigge, R. McLeod, and A.P. Kozikowski. ChemMedChem, 2013. 8(7): p. 1138-1160. ISI[000320928400010].

[WOS]. OI_0802-081513.